Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2021-12-28 Sale |
2021-12-30 5:12 pm |
SANGAMO THERAPEUTICS INC | SGMO | BIOGEN INC. Biogen MA Inc. 10% Owner |
2,764 | $8.5101 | $23,522 | 24,152,466 (Indirect) |
View |
| 2021-12-23 Sale |
2021-12-28 08:11 am |
SANGAMO THERAPEUTICS INC | SGMO | BIOGEN INC. Biogen MA Inc. 10% Owner |
81,787 | $8.5547 | $699,666 | 24,155,230 (Indirect) |
View |
| 2021-12-09 Sale |
2021-12-10 4:08 pm |
SANGAMO THERAPEUTICS INC | SGMO | BIOGEN INC. Biogen MA Inc. 10% Owner |
23,660 | $8.5605 | $202,541 | 24,237,017 (Indirect) |
View |
| 2021-12-07 Sale |
2021-12-09 4:08 pm |
SANGAMO THERAPEUTICS INC | SGMO | BIOGEN INC. Biogen MA Inc. 10% Owner |
127,992 | $8.5885 | $1,099,265 | 24,260,677 (Indirect) |
View |
| 2021-12-01 Sale |
2021-12-03 4:09 pm |
SANGAMO THERAPEUTICS INC | SGMO | BIOGEN INC. Biogen MA Inc. 10% Owner |
2,604 | $8.5123 | $22,166 | 24,388,669 (Indirect) |
View |
| 2021-11-26 Sale |
2021-11-30 4:20 pm |
SANGAMO THERAPEUTICS INC | SGMO | BIOGEN INC. Biogen MA Inc. 10% Owner |
28,884 | $8.6011 | $248,434 | 24,391,273 (Indirect) |
View |
| 2021-03-23 Sale |
2021-03-25 7:19 pm |
SANGAMO THERAPEUTICS INC | SGMO | LOEB GARY EVP, General Counsel & Sec. |
17,524 | $13.13 | $230,042 | 321,257 (Direct) |
View |
| 2020-12-31 Sale |
2021-01-06 4:27 pm |
SANGAMO THERAPEUTICS INC | SGMO | Ramelmeier Rolf Andrew EVP, Technical Operations |
2,464 | $16.74 | $41,247 | 65,978 (Direct) |
View |
| 2020-12-24 Sale |
2020-12-30 7:51 pm |
SANGAMO THERAPEUTICS INC | SGMO | Ramelmeier Rolf Andrew EVP, Technical Operations |
3,331 | $18.13 | $60,391 | 68,442 (Direct) |
View |
| 2020-12-17 Sale |
2020-12-18 7:18 pm |
SANGAMO THERAPEUTICS INC | SGMO | Ramasastry Saira Director |
10,000 | $13.27 | $132,747 | 15,000 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2022-02-12 Tax Withholding |
2022-02-24 5:32 pm |
N/A N/A |
SANGAMO THERAPEUTICS INC | SGMO | Schott Robert J. SVP, Head of Development |
5,463 | $5.76 | 34,537 (Direct) |
View |
| 2021-10-29 Tax Withholding |
2021-11-03 3:30 pm |
N/A N/A |
SANGAMO THERAPEUTICS INC | SGMO | Willoughby Scott B. SVP, Gen. Counsel & Secretary |
140 | $8.12 | 54,455 (Direct) |
View |
| 2021-08-13 Option Award |
2021-08-17 5:57 pm |
N/A 2031-08-12 |
SANGAMO THERAPEUTICS INC | SGMO | Willoughby Scott B. SVP, Gen. Counsel & Secretary |
22,500 | $0 | 69,595 (Direct) |
View |
Ownership |
2021-08-09 8:21 pm |
N/A N/A |
SANGAMO THERAPEUTICS INC | SGMO | Willoughby Scott B. SVP, Gen. Counsel & Secretary |
0 | $0 | 143,595 (Direct) |
View |
| 2021-06-25 Tax Withholding |
2021-06-29 7:55 pm |
N/A N/A |
SANGAMO THERAPEUTICS INC | SGMO | McClung David Mark EVP, Chief Business Officer |
11,525 | $12.02 | 129,294 (Direct) |
View |
| 2021-06-11 Option Award |
2021-06-14 7:17 pm |
N/A 2031-06-10 |
SANGAMO THERAPEUTICS INC | SGMO | Duraibabu Prathyusha SVP, CFO, PFO and PAO |
22,500 | $0 | 64,827 (Direct) |
View |
| 2021-04-25 Tax Withholding |
2021-04-27 8:49 pm |
N/A N/A |
SANGAMO THERAPEUTICS INC | SGMO | Fontenot Jason D. SVP, Chief Scientific Officer |
811 | $11.71 | 62,496 (Direct) |
View |
| 2021-04-25 Tax Withholding |
2021-04-27 8:49 pm |
N/A N/A |
SANGAMO THERAPEUTICS INC | SGMO | Duraibabu Prathyusha VP, PFO and PAO |
662 | $11.71 | 40,128 (Direct) |
View |
| 2021-03-25 Tax Withholding(A) |
2021-04-27 8:46 pm |
N/A N/A |
SANGAMO THERAPEUTICS INC | SGMO | Duraibabu Prathyusha VP, PFO and PAO |
345 | $12.27 | 40,790 (Direct) |
View |
| 2021-02-25 Option Award(A) |
2021-04-27 8:45 pm |
N/A 2031-02-24 |
SANGAMO THERAPEUTICS INC | SGMO | Duraibabu Prathyusha VP, PFO and PAO |
41,250 | $0 | 68,635 (Direct) |
View |
| 2021-02-25 Tax Withholding(A) |
2021-04-27 8:45 pm |
N/A N/A |
SANGAMO THERAPEUTICS INC | SGMO | Duraibabu Prathyusha VP, PFO and PAO |
1,863 | $11.19 | 68,635 (Direct) |
View |
| 2021-03-25 Tax Withholding |
2021-03-29 7:11 pm |
N/A N/A |
SANGAMO THERAPEUTICS INC | SGMO | Duraibabu Prathyusha VP, PFO and PAO |
345 | $12.27 | 40,790 (Direct) |
View |
| 2021-03-23 Exercise |
2021-03-25 7:19 pm |
N/A 2029-08-22 |
SANGAMO THERAPEUTICS INC | SGMO | LOEB GARY EVP, General Counsel & Sec. |
11,981 | $0 | 321,257 (Direct) |
View |
| 2021-03-23 Exercise |
2021-03-25 7:19 pm |
N/A N/A |
SANGAMO THERAPEUTICS INC | SGMO | LOEB GARY EVP, General Counsel & Sec. |
11,981 | $11.02 | 321,257 (Direct) |
View |
Ownership |
2021-03-19 7:15 pm |
N/A N/A |
SANGAMO THERAPEUTICS INC | SGMO | Fontenot Jason D. SVP, Chief Scientific Officer |
0 | $0 | 257,307 (Direct) |
View |
| 2021-02-25 Option Award |
2021-03-01 9:12 pm |
N/A 2031-02-24 |
SANGAMO THERAPEUTICS INC | SGMO | Duraibabu Prathyusha VP Principal Acct. Officer |
41,250 | $0 | 68,635 (Direct) |
View |
| 2021-02-25 Tax Withholding |
2021-03-01 9:12 pm |
N/A N/A |
SANGAMO THERAPEUTICS INC | SGMO | Duraibabu Prathyusha VP Principal Acct. Officer |
1,863 | $11.19 | 68,635 (Direct) |
View |
| 2021-02-25 Option Award |
2021-03-01 9:11 pm |
N/A 2031-02-24 |
SANGAMO THERAPEUTICS INC | SGMO | Ramelmeier Rolf Andrew EVP, Technical Operations |
120,000 | $0 | 178,199 (Direct) |
View |
| 2021-02-25 Tax Withholding |
2021-03-01 9:11 pm |
N/A N/A |
SANGAMO THERAPEUTICS INC | SGMO | Ramelmeier Rolf Andrew EVP, Technical Operations |
7,779 | $11.19 | 178,199 (Direct) |
View |
| 2021-02-25 Option Award |
2021-03-01 9:10 pm |
N/A 2031-02-24 |
SANGAMO THERAPEUTICS INC | SGMO | McClung David Mark EVP, Chief Business Officer |
120,000 | $0 | 220,000 (Direct) |
View |
| 2021-02-25 Option Award |
2021-03-01 9:09 pm |
N/A 2031-02-24 |
SANGAMO THERAPEUTICS INC | SGMO | LOEB GARY EVP, General Counsel & Sec. |
132,000 | $0 | 176,781 (Direct) |
View |
| 2021-02-25 Tax Withholding |
2021-03-01 9:09 pm |
N/A N/A |
SANGAMO THERAPEUTICS INC | SGMO | LOEB GARY EVP, General Counsel & Sec. |
5,762 | $11.19 | 176,781 (Direct) |
View |
| 2021-02-25 Option Award |
2021-03-01 9:08 pm |
N/A 2031-02-24 |
SANGAMO THERAPEUTICS INC | SGMO | Macrae Sandy President and CEO |
415,125 | $0 | 623,816 (Direct) |
View |
| 2021-02-25 Tax Withholding |
2021-03-01 9:08 pm |
N/A N/A |
SANGAMO THERAPEUTICS INC | SGMO | Macrae Sandy President and CEO |
35,311 | $11.19 | 623,816 (Direct) |
View |
| 2021-02-25 Option Award |
2021-03-01 9:07 pm |
N/A 2031-02-24 |
SANGAMO THERAPEUTICS INC | SGMO | Zakrzewski Joseph S Director |
24,600 | $0 | 64,600 (Direct) |
View |
| 2021-02-25 Option Award |
2021-03-01 9:05 pm |
N/A 2031-02-24 |
SANGAMO THERAPEUTICS INC | SGMO | Smith Karen L. Director |
24,600 | $0 | 42,100 (Direct) |
View |
| 2021-02-25 Option Award |
2021-03-01 9:04 pm |
N/A 2031-02-24 |
SANGAMO THERAPEUTICS INC | SGMO | Ramasastry Saira Director |
24,600 | $0 | 39,600 (Direct) |
View |
| 2021-02-25 Option Award |
2021-03-01 9:03 pm |
N/A 2031-02-24 |
SANGAMO THERAPEUTICS INC | SGMO | PARKER H STEWART Director |
24,600 | $0 | 47,600 (Direct) |
View |
| 2021-02-25 Option Award |
2021-03-01 9:01 pm |
N/A 2031-02-24 |
SANGAMO THERAPEUTICS INC | SGMO | Meyers James R Director |
24,600 | $0 | 39,600 (Direct) |
View |
| 2021-02-25 Option Award |
2021-03-01 8:59 pm |
N/A 2031-02-24 |
SANGAMO THERAPEUTICS INC | SGMO | Markels John Director |
24,600 | $0 | 29,600 (Direct) |
View |
| 2021-02-25 Option Award |
2021-03-01 8:57 pm |
N/A 2031-02-24 |
SANGAMO THERAPEUTICS INC | SGMO | Hillan Kenneth J. Director |
24,600 | $0 | 39,600 (Direct) |
View |
| 2021-02-25 Option Award |
2021-03-01 8:56 pm |
N/A 2031-02-24 |
SANGAMO THERAPEUTICS INC | SGMO | Carey Robert Director |
24,600 | $0 | 39,600 (Direct) |
View |
| 2021-02-12 Option Award |
2021-02-16 6:21 pm |
N/A 2031-02-11 |
SANGAMO THERAPEUTICS INC | SGMO | Schott Robert J. SVP, Head of Development |
120,000 | $0 | 120,000 (Direct) |
View |
| 2021-01-24 Tax Withholding |
2021-01-26 8:24 pm |
N/A N/A |
SANGAMO THERAPEUTICS INC | SGMO | Macrae Sandy President and CEO |
3,977 | $14.95 | 244,002 (Direct) |
View |
| 2020-12-17 Exercise |
2020-12-18 7:18 pm |
N/A 2026-06-13 |
SANGAMO THERAPEUTICS INC | SGMO | Ramasastry Saira Director |
10,000 | $0 | 15,000 (Direct) |
View |
| 2020-12-17 Exercise |
2020-12-18 7:18 pm |
N/A N/A |
SANGAMO THERAPEUTICS INC | SGMO | Ramasastry Saira Director |
10,000 | $5.99 | 15,000 (Direct) |
View |
| 2020-11-25 Tax Withholding |
2020-11-30 7:46 pm |
N/A N/A |
SANGAMO THERAPEUTICS INC | SGMO | Lee Sung EVP, Chief Financial Officer |
5,042 | $9.77 | 88,708 (Direct) |
View |
| 2020-09-09 Option Award |
2020-09-11 6:18 pm |
N/A 2030-09-08 |
SANGAMO THERAPEUTICS INC | SGMO | Hillan Kenneth J. Director |
45,000 | $0 | 45,000 (Direct) |
View |